Life Beyond Trauma: 1-on-1 e-Health Program for Parents of Neurodiverse Children

March 29, 2022 updated by: Patrick J. McGrath, IWK Health Centre

Parents of neurodiverse children are more likely to experience traumatic events related to the care of their child/children. This increases the probability to experience Posttraumatic Stress Injury (PTSI). However, interventions addressing PTSI symptoms in parents are rare.

In this research project the study investigators will test the feasibility and efficacy of e-NET, a distance-delivered, exposure-based intervention for PTSI adapted to the needs of parents of neurodiverse children. E-NET is an adapted version of the Narrative Exposure Therapy (NET), an evidence-based intervention approach for individuals with PTSI who have experienced repeated or continuous trauma. The intervention will be conducted via videoconferencing with trained paraprofessionals. During the intervention a narrative of both positive and negative (traumatic) experiences in the parents' life will be created. The intervention contains approx. 12 one-on-one sessions with a trained paraprofessional via videoconferencing.

The study design is a waitlist control group design. Approx. 20 participants will receive e-NET directly after the baseline survey and 20 participants will receive e-NET approx. 3 months after the baseline survey. To test the efficacy of the intervention, participants will fill out surveys about PTSI and other mental health symptoms before, directly after, and 2 and 6 months after the intervention. Adverse events and distress will be assessed in every session. As part of the baseline, participants will complete the survey "Surviving and Thriving in Parenting Neurodiverse Children" to determine their eligibility for the intervention. Main eligibility criterion is the presence of PTSI symptoms.

Study Overview

Study Type

Interventional

Enrollment (Actual)

66

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Nova Scotia
      • Halifax, Nova Scotia, Canada, B3K6R8
        • IWK Health Centre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria: Parent/Caregivers must meet the following criteria to be eligible to move on to Consent

  1. Be a parent/caregiver of a neurodiverse child
  2. Be at least 18 years of age
  3. Be able to understand spoken and written English at a Grade 8 level
  4. Fulfill the criteria of full or subclinical PTSI according to DSM-5, measured with the Life Events Checklist for DSM-5, the Parent Trauma Checklist and the PTSD Checklist for DSM-5. For this they have to report at least one traumatic event in the LEC-5 or the Stressful Life Experiences of Parents Checklist. To fulfill all PTSI criteria, the participant additionally needs to respond with "moderately" or higher in at least one item for the criteria B and C and two items for criteria D and E. Subclinical PTSI is fulfilled if the participant meets all but one criterion of B, C, D, or E is not met.
  5. Have access to a computer with high speed Internet
  6. Live in Canada
  7. Commit to the requirements of taking part in the study (12 weekly coaching calls)

Exclusion Criteria:

  1. Acute suicidal behavior or other extreme forms of self-destructive behavior
  2. Moderate to severe symptoms of dissociation
  3. Acute psychotic symptoms
  4. Previously participated in exposure intervention for PTSI/PTSD

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Immediate e-NET Group
Parents of neurodiverse children with PTSI will receive e-NET immediately after the baseline survey
One-on-one distance coached intervention; approx. 12 sessions at 60-90 minutes.
Experimental: Wait List Control Group
Parents of neurodiverse children with PTSI will receive e-NET 3 months after the baseline survey
One-on-one distance coached intervention; approx. 12 sessions at 60-90 minutes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in PTSI symptoms
Time Frame: Baseline, Immediately Post- intervention, 2 months post-intervention, 6 months post-intervention
PTSD symptoms are measured with the PTSD Checklist - 5 (PCL-5). Respondents are asked to rate how bothered they have been by each of 20 items in the past month on a 5- point Likert scale ranging from 0-4. Items are summed to provide a total severity score. Higher scores indicate a worse outcome
Baseline, Immediately Post- intervention, 2 months post-intervention, 6 months post-intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Overall Health
Time Frame: Baseline, Wait-list Baseline; through study completion, an average of 12 weeks; Immediately Post-assessment; 2 month follow up; 6 month follow up
General health will be measured with the questionnaire PROMIS Global Health Caregiver's general health
Baseline, Wait-list Baseline; through study completion, an average of 12 weeks; Immediately Post-assessment; 2 month follow up; 6 month follow up
Change in Depression Symptoms
Time Frame: Baseline, Immediately Post-assessment, 2 month follow up, 6 month follow up
Depression symptoms will be measured with the Patient Health Questionnaire (PHQ-9)
Baseline, Immediately Post-assessment, 2 month follow up, 6 month follow up
Change in overall functionality
Time Frame: Baseline; Wait list Baseline, Immediately Post intervention; 2 month follow up; 6 month follow up
Functionality will be measured with the Sheehan Disability Scale (SDS). SDS is measured on a 10-point scale (0-9). Higher score indicates a worse outcome.
Baseline; Wait list Baseline, Immediately Post intervention; 2 month follow up; 6 month follow up
Posttraumatic Growth
Time Frame: Baeline; Wait list Baseline; Immediately Post intervention; 2 month follow up; 6 month follow up
Posttraumatic growth will be measures using the Posttraumatic Growth Inventory - Short Form (PTGI ). The PTGI is measured on a 6-point Likert scale (score 0-5). Higher score indicates a better outcome.
Baeline; Wait list Baseline; Immediately Post intervention; 2 month follow up; 6 month follow up
Parent-child Relationship
Time Frame: Baseline; Wait list Baseline; Immediately Post intervention; 2 month follow up; 6 month follow up
The parent-child relationship will be measured with the Parent and Family Adjustment Scales (PAFAS). Items are rated from 0 to 3. Note that shaded items in the scoring key below must be reverse scored (i.e. 0=3, 1=2, 2=1, 3=0) before summing the Total Score. High scores indicate worse outcome.
Baseline; Wait list Baseline; Immediately Post intervention; 2 month follow up; 6 month follow up
Satisfaction with Lifeline Tool
Time Frame: During week 1 of intervention
The satisfaction with Lifeline Tool (self-constructed) will be measured with a self-constructed 3-item usability questionnaire. It is scored on a five point scale. Items are rated from 0-4. Higher score indicates better outcome.
During week 1 of intervention
Change in Anxiety Symptoms
Time Frame: Baseline, Immediately Post-assessment, 2 month follow up, 6 month follow up
Anxiety Symptoms are measured with the Generalized Anxiety Disorder (GAD-7). Items are scored on a four point scale, items are rated from 0-3. Higher score indicates better outcome.
Baseline, Immediately Post-assessment, 2 month follow up, 6 month follow up
Change in Physical Health Symptoms
Time Frame: Baseline; throughout study completion, approximately 12 week; Immediately Post-assessment; 2 month follow up; 6 month follow up
Physical Health symptoms will be assessed with the Patient Health Questionnaire Physical Symptoms (PHQ-15). Items are scored on a three point scale, items are rated from 0-2. Higher score indicates worse outcome.
Baseline; throughout study completion, approximately 12 week; Immediately Post-assessment; 2 month follow up; 6 month follow up
Adverse Events
Time Frame: throughout study completion, approximately 12 weeks; immediately post intervention
Adverse events will be assessed with a self-constructed questionnaire for adverse events, the course of symptoms during intervention and general distress.
throughout study completion, approximately 12 weeks; immediately post intervention
Therapeutic Alliance
Time Frame: Immediately post intervention
The interaction between coach and client will be assessed through the Therapeutic Alliance- Working Alliance Inventory - Short Form Revised (WAI-SR)
Immediately post intervention
Participant Satisfaction
Time Frame: Immediately Post intervention
Client satisfaction will be assessed with the Client Satisfaction Questionnaire (CSQ-8) and some additional (self-constructed) qualitative questions. CAQ-8 Items are scored on a four point scale, items are rated from 0-3. Higher score indicates worse outcome.
Immediately Post intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Patrick McGrath, PhD, IWK Health Centre
  • Principal Investigator: Elisa Kaltenbach, PhD, IWK Health Centre

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 29, 2020

Primary Completion (Actual)

August 31, 2021

Study Completion (Actual)

December 31, 2021

Study Registration Dates

First Submitted

March 23, 2020

First Submitted That Met QC Criteria

May 8, 2020

First Posted (Actual)

May 13, 2020

Study Record Updates

Last Update Posted (Actual)

March 31, 2022

Last Update Submitted That Met QC Criteria

March 29, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Post Traumatic Stress Disorder

Clinical Trials on e-Net for Parents of Neurodiverse Children

3
Subscribe